Children who are deaf or hard of hearing may experience higher rates of adverse childhood experiences (ACEs) than their ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

ModMed, Epic, NextGen Healthcare, Netsmart, athenahealth, and Specialty Category Innovators Lead Black Book's 2026 Ambulatory EHR Rankings NEW YORK CITY, NEW YORK / ACCESS Newswire / January 15, 2026 ...

A team of Mass General Brigham researchers has developed one of the first fully autonomous artificial intelligence (AI) systems capable of screening ...

Soon after the FDA’s guidance release, two other major AI announcements also hit the news: Utah began a first-in-the-nation ...

Neuroinfectious diseases, encephalitis, and neuroinflammation represent a diverse group of conditions that significantly ...

Thermo Fisher Scientific is acquiring Clario for roughly $8.9 billion, a major move to boost its clinical research services.

Muse Treatment Alcohol & Drug Rehab Los Angeles has published a new educational resource that explains how opioid receptors ...

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

Researchers report how Paenibacillus avoids harm by its own antibiotic — information that is crucial for developing new drug ...

Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...

Agentic AI is moving beyond automation to actively manage clinical complexity, streamline patient journeys and expand access ...